Skip to main content
FinSpry Logo
FinSpry
TCRX logo
TCRX
(NASDAQ)
TScan Therapeutics, Inc.
$0.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

TScan Therapeutics (TCRX) Stock Price & Financial Analysis

TScan Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.87 - $0.96
52-Week High$2.57
52-Week Low$0.85
Open$0.87
Volume494.90K
Average Volume (3M)528.88K
Market Cap114.44M
Shares Outstanding129.91M
Price to Sales (P/S)12.53
Price to Book (P/B)1.18
EV/EBITDA-0.75
Revenue (TTM)9.14M
Net Income (TTM)-124.31M
Free Cash Flow (TTM)-124.96M
EPS (TTM)$-0.96
Profit Margin-1360.61%
Operating Margin-1408.73%
Return on Equity (ROE)-128.25%
Debt to Equity1.08
50-Day MA$1.08
200-Day MA$1.25
52-Week Change-47.57%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About TScan Therapeutics

What is the current stock price for TCRX?

As of the latest trading session, TCRX stock trades at $0.92. The 52-week range is $0.85–$2.57, with a day range of $0.87–$0.95.

What is the P/E ratio for TCRX?

The P/E ratio (Price-to-Earnings) for TCRX is shown in the Key Statistics section. This valuation metric helps compare TScan Therapeutics, Inc. to industry peers.

Does TCRX pay dividends?

TScan Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TCRX?

Based on 4 analysts, the consensus for TCRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TCRX?

TScan Therapeutics's market capitalization is $119.7M, classifying it as a micro-cap company. TScan Therapeutics operates in the Healthcare sector within the Biotechnology industry.